We serve Chemical Name:Isosorbide CAS:652-67-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Isosorbide
CAS.NO:652-67-5
Synonyms:(3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furane-3,6-diol;Isosorbid;EINECS 211-492-3;D-Glucitol, 1,4:3,6-dianhydro-;D-Isosorbide;dianhydro-D-sorbitol;Isosorbide;dianhydro-D-glucitol;L-Glucitol, 1,4:3,6-dianhydro-;hydronol;1,4:3,6-Dianhydro-D-glucitol;D-1,4:3,6-Dianhydroglucitol;MFCD00064827;at101;1,4:3,6-dianhydrogluticol;IsMotic;(3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diol;isobide;1,4:3,6-dianhydro-D-sorbitol;devicoran;1,4:3,6-Dianhydro-L-glucitol
Molecular Formula:C6H10O4
Molecular Weight:146.141
HS Code:2932999099
Physical and Chemical Properties:
Melting point:60-63 °C(lit.)
Boiling point:372.1±42.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.562
PSA:58.92000
Exact Mass:146.057907
LogP:-1.75
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furane-3,6-diol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4:3,6-Dianhydro-L-glucitol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4:3,6-Dianhydro-L-glucitol Use and application,Isosorbid technical grade,usp/ep/jp grade.
Related News: For this study, researchers purchased 231 different cosmetics products in the United States and Canada and tested them for fluorine, Bruton said. Isosorbide manufacturer New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country. Isosorbide supplier The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. Isosorbide vendor For this study, researchers purchased 231 different cosmetics products in the United States and Canada and tested them for fluorine, Bruton said. Isosorbide factory The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. Isosorbide vendor For this study, researchers purchased 231 different cosmetics products in the United States and Canada and tested them for fluorine, Bruton said. Isosorbide factory The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.
